At the current stage, a lot of work has been completed.
We have made significant progress towards the project's goal of developing a system for continuous monitoring of blood glucose levels, CGM Fly.
Numerous negotiations were held and certain agreements were reached.
A contract was signed with a team of professionals, the MIET research centre. The first patent application was filed.
The first offline conference was held in Côte d'Ivoire, that attracted active leaders and partners.
We are successfully progressing according to the project development strategy and the risks have already been considerably reduced.
Please note, after going to the next stage - stage 5 - the price of shares will increase by 30%.
The stage change will take place on 01.08.2023!
Hurry up to purchase packages of shares at the beneficial price of the current stage!
